Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT06679777
Recruiting Observational

Swedish CArdioPulmonary bioImage Study 2

NCT06679777 · tracked via the Priya Life Science Sweden tracker
Sponsor
Karolinska Institutet
Phase
Observational
Started
2024-01-15
Last updated
2024-11-07

Condition(s) studied

Cardiovascular DiseasesLung Diseases

Study summary

In the Swedish CArdioPulmonary bioImage Study (SCAPIS 1), 30,154 randomly selected men and women, aged 50-64 years, were recruited from six areas in Sweden during 2013-2018. The study population was investigated with CCTA, ultrasound carotids, physical examination, questionnaires, accelerometry, ECG, spirometry, and biochemical markers. The aim was to obtain new information relevant to the identification and treatment of individuals with cardiopulmonary and metabolic diseases and to optimize the possibilities for studying disease mechanisms.

In SCAPIS-2, half of the individuals (n≈15,000) included in SCAPIS 1, will be re-examined 2024-2025 with the same investigations as during 2013-2018 except for ultrasound of the carotids.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: \- Participated in SCAPIS 1. Exclusion Criteria: * Individuals who have withdrawn their informed consent during or after SCAPIS 1.

Primary outcome measure(s)

  • Cardiovascular death, non-fatal myocardial infarction or stroke. — Through study completion, an average of 5 years
    Cardiovascular death, non-fatal myocardial infarction or stroke.

Trial sites (6)

FacilityCityRegionStatus
Gothenburg University Gothenburg Sweden Recruiting
Linköping University Linköping Sweden Recruiting
Lund University Lund Sweden Recruiting
Karolinska Institutet Stockholm Sweden Recruiting
Umeå Universitet Umeå Sweden Recruiting
Uppsala University Uppsala Sweden Recruiting

More Karolinska Institutet trials in Sweden

Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study Active, not recruiting
Implementation of Evidence-based Guidelines for Assessment and Counseling of Patients With Neck and Back Pain in Health Care Centers Starting soon
Single Nuclei Sequencing in Human Skeletal Muscle After Unloading Enrolling by invitation
Validation of a Novel Smartphone-based Method for Heart Rhythm Monitoring in the Home Environment Active, not recruiting
Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer Recruiting

Other trials for the same condition

The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality Recruiting
Prospective Urban Rural Epidemiology Study Recruiting
Evaluation of Cascade Screening for Elevated Lipoprotein(a) Active, not recruiting
An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study Enrolling by invitation
A Digital Lifestyle Intervention in Primary Healthcare to Prevent Cardiovascular Disease Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06679777 on ClinicalTrials.gov ↗ ← All trials in Sweden